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Abstract Interleukin-1 (IL-1) stimulates the association of the
IL-1 receptor-associated protein kinase (IRAK) with the
heterodimer of IL-1RI and IL-1RAcP via the adapter protein
MyD88. In the receptor complex IRAK becomes heavily
phosphorylated and concomitantly activated. Here we show that
overexpression of a kinase-inactive mutant of IRAK (K239S)
inhibits neither IL-1-stimulated activation of the transcription
factor NF-UB, nor that of the c-Jun N-terminal kinase nor IL-2
production in murine EL-4 cells, but enhances these effects in a
manner comparable to wild type IRAK. This strongly suggests
that the intrinsic kinase activity is not required for downstream
signaling via IRAK.
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1. Introduction
Interleukin-1 (IL-1) is an important pro-in£ammatory cyto-
kine centrally involved in the activation of the immune re-
sponse [1]. IL-1 binds to two speci¢c plasma membrane re-
ceptors which both belong to the IL-1 receptor/Toll family [2].
Active signaling complexes are formed by the association of
IL-1RAcP with ligated IL-1RI [3,4]. The cytoplasmic domains
of both IL-1RI and IL-1RAcP are required for IL-1 signaling
to occur [5^7]. Very rapidly after IL-1 stimulation of cells, a
serine/threonine-speci¢c protein kinase activity can be copre-
cipitated with the IL-1RI [8^10]. This kinase was cloned and
termed IL-1 receptor-associated kinase (IRAK) [11]. IRAK
associates with the IL-1RI/IL-1RAcP heterodimer via the
adaptor protein MyD88 involving the interaction of the
‘death domains’ in IRAK and MyD88, respectively [12^14].
In the active IL-1 receptor complex IRAK becomes heavily
phosphorylated, strongly suggesting that IRAK auto- or
crossphosphorylates and thus activates itself for downstream
signaling events, namely the interaction with TRAF6 [15],
leading to activation of the transcription factor NF-UB.
On the other hand, it was suggested that hyperphosphoryl-
ation of IRAK is a signal for rapid proteolytic degradation
by a proteasome-dependent mechanism [16]. Thus, it is cur-
rently unclear whether the kinase activity of IRAK is indis-
pensable for the initiation of downstream signaling, i.e. by
phosphorylating subsequent target molecules, or whether the
phosphorylation is only involved in regulating the stability of
IRAK molecules.
In order to elucidate the requirement of IRAK’s kinase
activity in IL-1 signaling we employed a kinase-inactive mu-
tant of human IRAK (K239S). Here we show that overex-
pression of IRAK (K239S) over a background of endogenous
murine IRAK surprisingly neither negatively a¡ects IL-1-
stimulated activation of the transcription factor NF-UB, nor
the activation of the c-Jun N-terminal kinase (JNK), nor the
IL-1-induced IL-2 production of EL-4 cells. In contrast,
IRAK (K239S) behaves like wild type IRAK with respect to
the IL-1 signaling events determined, suggesting that the in-
trinsic kinase activity of IRAK and hyperphosphorylation of
IRAK are not essential for IL-1-stimulated signaling.
2. Materials and methods
2.1. Expression vectors and transfection
Mammalian expression vectors encoding wild type human IRAK
(pRK5-IRAK) and human IRAK with a defect ATP binding site
(IRAK K239S) were kind gifts of Z. Cao (Tularik Inc., South San
Francisco, CA, USA) and have been described [13]. The control plas-
mid pRK5* was generated from pRK5-IRAK by excising the insert.
The NF-UB-luciferase reporter gene construct 5UNF-UB-luc was
kindly provided by W. Falk (Regensburg, Germany). The plasmid
pHA-JNK1 encoding N-terminal HA-tagged human JNK1 [17] was
generated by the polymerase chain reaction (PCR) cloning technique.
EL-4 6.1 were maintained at 37‡C, 5% CO2 in RPMI 1640 supple-
mented with 5% (v/v) fetal calf serum and transiently transfected using
the DEAE-dextran procedure exactly as described previously [18]. In
all experiments, the amount of transfected DNA was kept constant by
adding control plasmid.
2.2. Detection of IRAK protein and kinase activity
For immunoprecipitation of IRAK 1U107 cells were transfected
with the indicated amounts of expression constructs. 24 h after trans-
fection cells were either left untreated or stimulated with rhIL-1L (10
ng/ml, DompeŁ, L’Aquila, Italy) at 37‡C for the times indicated. Cells
were collected, washed and lysed for 30 min in a lysis bu¡er contain-
ing 50 mM HEPES pH 7.9, 250 mM NaCl, 20 mM glycerophosphate,
5 mM p-nitrophenylphosphate, 1 mM EDTA-Na2, 1 mM Na-ortho-
vanadate, 0.5% (v/v) Nonidet P-40, 10% (v/v) glycerol, 5 mM DTT
and protease inhibitors (Complete, Roche Diagnostics, Mannheim,
Germany). Nuclei and cellular debris were removed by centrifugation
(13 000Ug, 30 min, 4‡C). IRAK was precipitated with 0.5 Wl of a
polyclonal serum (kindly provided by Z. Cao) and 25 Wl of 50% (v/
v) protein G-Sepharose slurry (Pharmacia, Freiburg, Germany). Im-
munoprecipitates were subjected to an in vitro kinase assay using
myelin basic protein (MBP, Sigma, Deisenhofen, Germany) as exog-
enous substrate as previously described [8]. Phosphorylated proteins
were separated by SDS-PAGE and visualized by phosphoimaging.
2.3. Western blotting
Immunoprecipitates were heated in SDS sample bu¡er, proteins
separated by SDS-PAGE, and transferred to PVDF membranes.
Membranes were incubated with the indicated antibodies and reactive
bands were visualized with horseradish peroxidase-coupled secondary
antibodies by an enhanced chemoluminescence detection system
(Pierce, Rockford, IL, USA).
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2.4. Reporter gene assays
For detection of NF-UB-dependent reporter gene activity, 5U106
cells were cotransfected with the indicated expression constructs and
0.5 Wg 5UNF-UB-luc. After 4 h, cells were either left untreated, or
stimulated with 10 ng/ml rhIL-1L or 100 ng/ml rhTNFK (BASF AG,
Ludwigshafen, Germany) for an additional 20 h before harvest. Lu-
ciferase activity was determined using the Luciferase Assay System
(Promega, Mannheim, Germany) and normalized on the basis of pro-
tein concentration as measured according to Bradford [19] with re-
agents from Bio-Rad (Munich, Germany).
2.5. In vitro SAP kinase assay
As a representative of SAP kinases the activity of cotransfected c-
Jun N-terminal kinase was measured. 1U107 cells were cotransfected
with the indicated expression constructs and 0.5 Wg pHA-JNK1. After
24 h, cells were either left untreated, or stimulated with 10 ng/ml
rhIL1L or 0.5 M sorbitol for 15 min. Cells were lysed as described
in Section 2.2 and JNK1 was precipitated with 0.5 Wg of the mono-
clonal anti-HA antibody (12CA5, ATCC) and 25 Wl of 50% (v/v)
protein G-Sepharose slurry (Pharmacia, Freiburg). One half of the
immunoprecipitates was subjected to an in vitro kinase assay using
recombinant GST-c-Jun(1^79) (Stratagene, Heidelberg, Germany) as
substrate exactly as described [4]. The second half of the immunopre-
cipitates was used to control JNK1 expression by immunoblotting
with the antibody 12CA5.
2.6. Quanti¢cation of IL-2 production by ELISA technique
5U106 cells were transfected with the indicated expression con-
structs. After 4 h, the cells were left untreated or stimulated with 10
ng/ml rhIL-1L for an additional 20 h. Supernatants were collected and
IL-2 was measured using antibody pairs for mouse IL-2 according to
the manufacturer’s instructions (BioSOURCE Europe, Fleurus, Bel-
gium).
3. Results
3.1. Mutant human IRAK (K239S) is not enzymatically active
An in vitro kinase assay was performed with IRAK immu-
noprecipitated from transiently transfected EL-4 cells in the
presence of the exogenous substrate MBP. While background
phosphorylation in untreated cells was barely detectable, IL-1
stimulation of endogenous murine IRAK (which was also
precipitated by the antiserum) for 10 or 60 min resulted in
autophosphorylation (Fig. 1A, control, upper panel) and
phosphorylation of MBP (Fig. 1A, control, lower panel).
Overexpression of human IRAK (wt) resulted in a pro-
nounced phosphorylation in the range of 80^100 kDa upon
IL-1 stimulation most likely due to auto- or crossphospho-
rylation of the immunoprecipitated human IRAK (Fig. 1A,
IRAK (wt), upper panel). Furthermore, the exogenous sub-
strate MBP became phosphorylated (Fig. 1A, IRAK (wt),
lower panel). If mutant IRAK (K239S) was overexpressed
in EL-4 cells only the weak phosphorylation of endogenous
murine IRAK was detectable after IL-1 stimulation and no
additional phosphorylation of mutant IRAK (K239S) was
observed (Fig. 1A, IRAK (K239S), upper panel).
Protein expression of human IRAK (wt) and IRAK
(K239S) in transiently transfected cells was checked by West-
ern blotting. While no signal was detectable in vector-only
transfected cells (expression of endogenous murine IRAK in
EL-4 cells is below the detection limit, Fig. 1B, control),
signals were observed in EL-4 cells transfected with either
human IRAK (wt) or IRAK (K239S) (Fig. 1B). Consistently,
more protein of IRAK (K239S) was detected than of IRAK
(wt) if the same concentration of plasmids were used for
transfection.
3.2. Kinase-inactive IRAK (K239S) is not dominant negative
for IL-1-stimulated NF-UB transactivating activity but can
activate NF-UB in an IL-1-dependent manner
IL-1 and tumor necrosis factor (TNF) stimulated the acti-
vation of the transcription factor NF-UB in EL-4 cells as
measured by a NF-UB-dependent luciferase reporter system
(Fig. 2, control). Transient overexpression of human IRAK
(wt) resulted in a strong increase in IL-1-stimulated reporter
gene expression, whereas TNF-stimulated NF-UB activity re-
mained unchanged (Fig. 2, IRAK (wt)). Overexpression of
kinase-inactive IRAK (K239S) yielded the same result. While
TNF-stimulated NF-UB activity remained una¡ected, IL-1-
stimulated NF UB activity by far exceeded the level achieved
in mock-transfected cells.
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Fig. 1. Detection of IRAK activity (in vitro kinase assay, A) and
IRAK protein (immunoblot, B). 1U107 EL-4 cells were transfected
with 0.1 Wg (A) or 0.5 Wg (B) control plasmid or vectors encoding
IRAK (wt) or IRAK (K239S), respectively. After 24 h cells were
stimulated with 10 ng/ml rhIL-1L for 0, 10 or 60 min. IRAK was
precipitated from cell lysates using an anti-IRAK antiserum. Immu-
noprecipitates were subjected to an in vitro kinase assay with MBP
as exogenous substrate (A) or immunoblotted with the anti-IRAK
antiserum (B).
Fig. 2. E¡ect of IRAK (K239S) expression on IL-1-stimulated NF-
UB activation. 5U106 EL-4 cells were transiently transfected with
0.5 Wg of the reporter plasmid 5UNF-UB-luc and the indicated vec-
tor constructs. After 4 h, cells were either left untreated or were
stimulated with 10 ng/ml rhIL-1L or 100 ng/ml TNF-K for 20 h.
Luciferase activities were determined and normalized on the basis of
protein concentration. Three independent experiments produced sim-
ilar results.
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3.3. Kinase-inactive IRAK (K239S) does not inhibit
IL-1-stimulated activation of c-Jun N-terminal kinase
but activates JNK in an IL-1-dependent manner
In EL-4 cells transfected with vector only IL-1 and osmotic
stress (0.5 M sorbitol) stimulated the activation of JNK. Tran-
sient overexpression of IRAK (wt) resulted in an increase in
IL-1-stimulated GST-c-Jun phosphorylation (Fig. 3A, upper
panel, Fig. 3B, left panel). Overexpression of kinase-inactive
IRAK (K239S) also led to a strong IL-1-dependent stimula-
tion of JNK activity (Fig. 3A, lower panel, Fig. 3B, right
panel). The stress-induced phosphorylation of GST-c-Jun
was una¡ected by overexpression of either IRAK (wt) or
IRAK (K239S).
3.4. Overexpression of IRAK (wt) or kinase-inactive IRAK
(K239S) leads to an increase in IL-1-dependent IL-2
synthesis and release
Unstimulated EL-4 cells do not produce IL-2. IL-1 weakly
induced the synthesis and release of IL-2 (Fig. 4, control).
This IL-1-dependent release of IL-2 was greatly enhanced by
overexpression of IRAK (wt) (Fig. 4, IRAK (wt)), an e¡ect
previously described for permanent EL-4 clones expressing
human IRAK (wt) [18]. Overexpression of IRAK (K239S)
did not abolish but enhanced IL-1-stimulated IL-2 synthesis
in a fashion qualitatively comparable to IRAK (wt) (Fig. 4,
IRAK (K239S)).
In all parameters used as readout, IL-1-stimulated signals
from EL-4 cells transiently transfected with IRAK (K239S)
tended to exceed those achieved with IRAK (wt). This e¡ect is
most likely due to the higher protein levels detected for IRAK
(K239S) by Western blotting.
4. Discussion
IRAK is a central element in IL-1 signaling. Permanent
overexpression of IRAK enhanced and prolonged IL-1-stimu-
lated activation of NF-UB and JNK in EL-4 cells [18], while
IRAK-de¢cient murine embryonal ¢broblasts showed a dras-
tically reduced response to IL-1 [20]. Upon IL-1 stimulation,
IRAK is recruited to the IL-1 receptor complex and auto- or
crossphosphorylates itself, leading to a pronounced shift in
electrophoretic mobility of IRAK from 80 to 100 kDa [11].
This hyperphosphorylation precedes interaction with TRAF6,
a molecule coupling IRAK to downstream e¡ectors such as
NIK [15]. By analogy to other protein kinases in cytokine
signaling, it is commonly assumed that the enzymatic activity
of IRAK is required for IL-1-dependent activation of itself,
allowing phosphorylation of downstream components respon-
sible for relaying the IL-1 signal to the level of transcription
factors such as NF-UB and AP-1. However, no endogenous
substrate for IRAK has been molecularly identi¢ed yet, which
is required for IL-1 signaling. Recently, a homologue of
IRAK, IRAK-2, was identi¢ed by EST database search [12],
which is not active as a kinase (Muzio and Wesche, personal
communication) but is able to activate NF-UB if overex-
pressed. In addition, a recently published abstract [21] sug-
gests that IRAK’s kinase activity may not be required for
IL-1 signaling.
In order to address the question whether IRAK’s enzymatic
activity is required to allow downstream signaling, we ex-
pressed a mutant form of human IRAK (K293S) in murine
EL-4 cells. In this mutant, the lysine residue 239 in the ATP
binding site was mutated to serine. It is well known that over-
expression of the N-terminal half of IRAK abrogates IL-1-
stimulated NF-UB activation in human 293 [12] and mouse
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Fig. 3. In£uence of IRAK (K239S) expression on IL-1-stimulated
JNK activation. 5U106 EL-4 cells were transfected with 0.5 Wg of
the plasmid pHA-JNK1 and the indicated expression constructs.
After 24 h, cells were either left untreated (3) or were stimulated
with 10 ng/ml rhIL-1L (+) or 0.5 M sorbitol (S) for 15 min. Epi-
tope-tagged JNK1 was precipitated from cell lysates using the anti-
HA antibody 12CA5. Immunoprecipitates were subjected to an in
vitro kinase assay with GST-c-Jun as exogenous substrate (A).
Phosphorylation signals were quantitated densitometrically (B) and
normalized on the basis of JNK1 expression as detected by Western
blot analysis of the immunoprecipitates with the anti-HA antibody
(data not shown). Three independent experiments produced similar
results.
Fig. 4. For quanti¢cation of IL-1-stimulated IL-2 production, cells
were transiently transfected with the indicated expression vectors for
4 h and were subsequently left untreated or were stimulated with 10
ng/ml rhIL-1L for 18 h. IL-2 released into the supernatant was
measured by ELISA (IL-2 production of unstimulated cells was be-
low the detection limit of 15.6 pg/ml). Bars express the means of
quadruplicate values from one out of two experiments with similar
results.
J. Knop, M.U. Martin/FEBS Letters 448 (1999) 81^85 83
EL-4 cells [18]. If kinase activity is required for IL-1 signaling,
one would expect a kinase-inactive IRAK molecule to behave
as dominant negative inhibitor upon overexpression.
Overexpression of human IRAK (wt) resulted in strong
autophosphorylation after IL-1 treatment. This is in accord-
ance with results obtained in EL-4 clones permanently ex-
pressing human IRAK (wt) [18], showing that intact human
IRAK can be activated by the murine IL-1 receptor system
and will phosphorylate itself and the exogenous substrate
MBP in vitro. The mutant form of IRAK (K239S) was not
capable of autophosphorylating itself nor was IRAK (K239S)
protein phosphorylated by endogenous murine IRAK in this
in vitro kinase assay.
Surprisingly, in none of the parameters used as readout for
IL-1 signaling events, kinase-inactive IRAK (K239S) behaved
as dominant negative inhibitor. In contrast, upon overexpres-
sion of IRAK (wt) as well as IRAK (K239S), we observed a
strong enhancement of IL-1-stimulated NF-UB-dependent re-
porter gene activity. The same results were obtained for the
activation of JNKs, which was clearly not reduced but en-
hanced by kinase-inactive IRAK (K239S). Moreover, IL-1-
stimulated IL-2 production was not inhibited but clearly en-
hanced by overexpressing IRAK (K239S). No qualitative dif-
ference was seen between expression of IRAK (wt) or IRAK
(K239S), underlining the fact that kinase-inactive IRAK
(K239S) was de¢nitely not dominant negative in this complex
bioresponse of EL-4 cells.
The question arises what the role of the kinase activity of
IRAK (wt) may be if it is not required for initiating down-
stream signaling events. In the normal situation IRAK (and
presumably IRAK-2) will be recruited to the heterodimer of
IL-1RI and IL-1RAcP by MyD88 upon IL-1 stimulation. One
assumes that IRAK autophosphorylates itself and crossphos-
phorylates IRAK-2. The observation that only unphosphoryl-
ated IRAK can be coprecipitated with MyD88 [13] suggests
that phosphorylation of IRAK may be the signal to leave the
receptor complex, allowing interaction with TRAF6 [15]. It
remains to be seen whether kinase-inactive IRAK (K239S)
can interact with TRAF6 in a similar way. On the other
hand, it is conceivable that unphosphorylated kinase-inactive
IRAK (K239S) may activate components of the NF-UB path-
way independently of TRAF6. Thus it was recently described
that casein kinase II in£uences IL-1-mediated NF-UB activa-
tion [22] and phosphatidylinositol 3-kinase is discussed to be
involved in IL-1 signaling [23,24]. In both cases, the coupling
mechanisms to the activated IL-1 receptor complex and
IRAK remain elusive. To this end it is noteworthy that IL-1
responses (activation of NF-UB and JNKs) were drastically
reduced but not completely abolished in IRAK-de¢cient em-
bryonal ¢broblasts [20] suggesting that either IRAK2 or yet to
be discovered members of the IRAK family can compensate
for the lack of IRAK to a certain extent. Another possibility
is that other pathways may lead to partial activation of NF-
UB and JNKs independently of IRAK’s presence.
Recently, it was shown that after association of IRAK to
the activated IL-1 receptor complex hyperphosphorylated
IRAK disappears not only from this complex but also from
the cytosolic pool. This process was inhibited by proteasome
inhibitors, suggesting that hyperphosphorylation of IRAK is
the signal to remove IRAK from the receptor complex by
proteolytic cleavage [16]. It is conceivable that under physio-
logical conditions the availability of IRAK to replenish hyper-
phosphorylated molecules removed from the receptor complex
is limited, thus regulating subsequent IL-1-stimulated signal-
ing events. This would explain our observation that perma-
nent overexpression of IRAK leads to prolonged kinetics of
NF-UB and JNK activation [18]. If autophosphorylation is the
signal for initiating the removal and proteolytic breakdown of
IRAK, kinase-inactive IRAK (K239S), which is not phos-
phorylated upon IL-1 stimulation, should persist longer in
the active signaling complex. This possibly explains the ob-
served di¡erences in expression of IRAK protein and the ad-
ditional increase in IL-1 responses caused by IRAK (K239S)
in comparison to IRAK (wt), which readily autophosphoryl-
ates itself and therefore is prone to the downregulatory path-
way.
In conclusion, growing evidence points to the fact that the
molecular way of action of IRAK may be di¡erent from that
of other kinases involved in cytokine signaling: IRAK seems
to be a highly sophisticated adaptor protein which in concert
with its partner TRAF6 can activate the downstream kinase
NIK in a manner currently unclear. For this function its kin-
ase activity may not be required. In addition IRAK autophos-
phorylates itself at multiple residues and thus initiates its own
removal from the receptor complex and its subsequent degra-
dation by proteolytic cleavage. By this mechanism it may
terminate signaling through the active IL-1 receptor complex.
Thus IRAK, once activated, may be a self-limiting adaptor of
IL-1 signaling possibly protecting target cells from prolonged
activation. This would be a novel mechanism of autocatalyzed
downregulation of the IL-1 signaling machinery.
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